Preface |
|
ix | |
Abbreviations Used in This Manual |
|
xi | |
Generic Medications and Brand-Name Equivalents |
|
xii | |
|
|
1 | (12) |
|
|
1 | (1) |
|
|
2 | (1) |
|
The drug development process |
|
|
3 | (5) |
|
Ethical issues related to cancer therapy |
|
|
8 | (1) |
|
Legal issues related to cancer therapy |
|
|
9 | (4) |
|
Cancer Therapy Goals and Response |
|
|
13 | (5) |
|
|
13 | (1) |
|
Factors affecting response to treatment |
|
|
13 | (1) |
|
|
14 | (4) |
|
Principles of Chemotherapy |
|
|
18 | (18) |
|
|
18 | (1) |
|
|
18 | (18) |
|
|
36 | (17) |
|
Theory of immune surveillance |
|
|
36 | (1) |
|
Methods of biotherapeutic action |
|
|
36 | (1) |
|
|
36 | (1) |
|
Therapeutic uses for biotherapeutic agents |
|
|
36 | (1) |
|
Supportive uses for biotherapeutic agents |
|
|
36 | (1) |
|
Uses for biotherapeutic agents in research |
|
|
36 | (8) |
|
Biotherapeutic strategies |
|
|
44 | (1) |
|
Actions of the immune system |
|
|
44 | (1) |
|
|
44 | (2) |
|
Cells of the immune system |
|
|
46 | (2) |
|
|
48 | (1) |
|
Angiogenesis and antiangiogenic agents |
|
|
49 | (1) |
|
Principles of radioimmunotherapy |
|
|
49 | (1) |
|
Toxin-conjugated molecules |
|
|
49 | (4) |
|
Fundamentals of Administration |
|
|
53 | (25) |
|
|
53 | (10) |
|
|
63 | (5) |
|
|
68 | (2) |
|
|
70 | (8) |
|
Immediate Complications of Cytotoxic Therapy |
|
|
78 | (11) |
|
|
78 | (5) |
|
|
83 | (1) |
|
Hypersensitivity and anaphylaxis |
|
|
83 | (3) |
|
Patient and family education |
|
|
86 | (3) |
|
Care of the Patient Receiving Cancer Therapy |
|
|
89 | (4) |
|
|
89 | (1) |
|
|
89 | (4) |
|
Side Effects of Cancer Therapy |
|
|
93 | (126) |
|
|
93 | (16) |
|
Gastrointestinal and mucosal side effects |
|
|
109 | (30) |
|
|
139 | (1) |
|
|
140 | (4) |
|
|
144 | (23) |
|
|
167 | (13) |
|
|
180 | (2) |
|
|
182 | (4) |
|
|
186 | (6) |
|
|
192 | (5) |
|
|
197 | (1) |
|
Alterations in sexuality and reproductive function |
|
|
198 | (8) |
|
|
206 | (1) |
|
|
206 | (7) |
|
|
213 | (6) |
|
|
219 | (7) |
|
|
219 | (1) |
|
Classification of effects |
|
|
219 | (1) |
|
|
219 | (6) |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
227 | (12) |
|
Appendix 1. Nursing Flow Sheet |
|
|
227 | (4) |
|
Appendix 2. Chemotherapy Flow Sheet |
|
|
231 | (2) |
|
Appendix 3. Safe Management of Chemotherapy in the Home |
|
|
233 | (2) |
|
Appendix 4. Progression of Intravenous Extravasation |
|
|
235 | (1) |
|
Appendix 5. Clinical Practicum Evaluation: Part I |
|
|
236 | (1) |
|
Appendix 6. Clinical Practicum Evaluation: Part II |
|
|
237 | (2) |
Index |
|
239 | |